LYRM4

Yuan Xu1, Yanting Yang2, Xinyuan Yu3

  • 1Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Weifang, 261053, Shandong Province, PR China; Shandong Provincial Key Laboratory of Precision Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong Province, PR China.

概括

遗传倾向在肝癌 (HCC) 中起作用. 在LYRM4基因增强剂中,一种特定的基因变异 (rs399283) 通过改变烟酸水平来影响HCC的发展,从而提供了一个潜在的新治疗标.